RNAC

RNAC Stock-Based Compensation

$9.24MTTM · USD

Period ending:

RNAC FY Stock-Based CompUSD
RNAC FY Stock-Based Comp2014-12-31: $1.22M2015-12-31: $0.002016-12-31: $0.002017-12-31: $0.002018-12-31: $0.002019-12-31: $0.002020-12-31: $5.42M2021-12-31: $7.72M2022-12-31: $11.19M2023-12-31: $22.52M2024-12-31: $6.58M2025-12-31: $10.52M$22.52M$0.00
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RNAC stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Cartesian Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
10,521,000
6,582,000
22,524,000
11,194,000
7,720,000
5,422,000
0
0
0
0
0
1,224,000

Compare stock-based compensation

All RNAC financial metrics · RNAC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.